BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

290 related articles for article (PubMed ID: 17270673)

  • 1. Association between vision loss and higher medical care costs in Medicare beneficiaries costs are greater for those with progressive vision loss.
    Javitt JC; Zhou Z; Willke RJ
    Ophthalmology; 2007 Feb; 114(2):238-45. PubMed ID: 17270673
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Medical care cost of Medicare/Medicaid beneficiaries with vision loss.
    Morse AR; Pyenson BS
    Ophthalmic Epidemiol; 2009; 16(1):50-7. PubMed ID: 19191182
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Eye-related medicare costs for patients with age-related macular degeneration from 1995 to 1999.
    Coleman AL; Yu F
    Ophthalmology; 2008 Jan; 115(1):18-25. PubMed ID: 17572499
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Costs and utilization of end-stage glaucoma patients receiving visual rehabilitation care: a US multisite retrospective study.
    Gieser DK; Tracy Williams R; O'Connell W; Pasquale LR; Rosenthal BP; Walt JG; Katz LM; Siegartel LR; Wang L; Rosenblatt LC; Stern LS; Doyle JJ
    J Glaucoma; 2006 Oct; 15(5):419-25. PubMed ID: 16988605
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Association of Vision Loss With Hospital Use and Costs Among Older Adults.
    Morse AR; Seiple W; Talwar N; Lee PP; Stein JD
    JAMA Ophthalmol; 2019 Jun; 137(6):634-640. PubMed ID: 30946451
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Impact of vision loss on costs and outcomes in medicare beneficiaries with glaucoma.
    Bramley T; Peeples P; Walt JG; Juhasz M; Hansen JE
    Arch Ophthalmol; 2008 Jun; 126(6):849-56. PubMed ID: 18541852
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The economic burden of vision loss and eye disorders among the United States population younger than 40 years.
    Wittenborn JS; Zhang X; Feagan CW; Crouse WL; Shrestha S; Kemper AR; Hoerger TJ; Saaddine JB;
    Ophthalmology; 2013 Sep; 120(9):1728-35. PubMed ID: 23631946
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Burden of chronic obstructive pulmonary disease in Medicare beneficiaries residing in long-term care facilities.
    Simoni-Wastila L; Blanchette CM; Qian J; Yang HW; Zhao L; Zuckerman IH; Pak GH; Silver H; Dalal AA
    Am J Geriatr Pharmacother; 2009 Oct; 7(5):262-70. PubMed ID: 19948302
    [TBL] [Abstract][Full Text] [Related]  

  • 9. LXIII Edward Jackson Memorial Lecture: Eye care: dollars and sense.
    Taylor HR
    Am J Ophthalmol; 2007 Jan; 143(1):1-8. PubMed ID: 17188039
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Trends in cost of major eye diseases to Medicare, 1991 to 2000.
    Salm M; Belsky D; Sloan FA
    Am J Ophthalmol; 2006 Dec; 142(6):976-82. PubMed ID: 17157582
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The impact of managed eye care on use of vision services, vision costs, and patient satisfaction.
    Colman SS; Jones RD; Serdahl CL; Smith FM; Silva SJ; Schonfeld WH
    Value Health; 2004; 7(2):195-203. PubMed ID: 15164809
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Economic impact of visual impairment and blindness in the United States.
    Frick KD; Gower EW; Kempen JH; Wolff JL
    Arch Ophthalmol; 2007 Apr; 125(4):544-50. PubMed ID: 17420375
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Vision impairment and major causes of vision loss impacts on vision-specific functioning independent of socioeconomic factors.
    Chiang PP; Zheng Y; Wong TY; Lamoureux EL
    Ophthalmology; 2013 Feb; 120(2):415-22. PubMed ID: 23149127
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Impact of donepezil use in routine clinical practice on health care costs in patients with Alzheimer's disease and related dementias enrolled in a large medicare managed care plan: a case-control study.
    Lu S; Hill J; Fillit H
    Am J Geriatr Pharmacother; 2005 Jun; 3(2):92-102. PubMed ID: 16129386
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Nonoperative care to manage sacroiliac joint disruption and degenerative sacroiliitis: high costs and medical resource utilization in the United States Medicare population.
    Ackerman SJ; Polly DW; Knight T; Holt T; Cummings J
    J Neurosurg Spine; 2014 Apr; 20(4):354-63. PubMed ID: 24527824
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The impact of including future medical care costs when estimating the costs attributable to a disease: a colorectal cancer case study.
    Etzioni R; Ramsey SD; Berry K; Brown M
    Health Econ; 2001 Apr; 10(3):245-56. PubMed ID: 11288190
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Evaluation of Medicare costs of endophthalmitis among patients after cataract surgery.
    Schmier JK; Halpern MT; Covert DW; Lau EC; Robin AL
    Ophthalmology; 2007 Jun; 114(6):1094-9. PubMed ID: 17320963
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The cost of vision loss in Canada. 1. Methodology.
    Gordon KD; Cruess AF; Bellan L; Mitchell S; Pezzullo ML
    Can J Ophthalmol; 2011 Aug; 46(4):310-4. PubMed ID: 21816248
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Economic burden associated with Parkinson's disease on elderly Medicare beneficiaries.
    Noyes K; Liu H; Li Y; Holloway R; Dick AW
    Mov Disord; 2006 Mar; 21(3):362-72. PubMed ID: 16211621
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The cost of vision loss in Canada. 2. Results.
    Cruess AF; Gordon KD; Bellan L; Mitchell S; Pezzullo ML
    Can J Ophthalmol; 2011 Aug; 46(4):315-8. PubMed ID: 21816249
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 15.